Title : Cannabis and Cannabinoids in brain diseases : An update on their therapeutic potential
In order to assess the current therapeutic potential of cannabis and cannabinoids in brain diseases, a meta-analysis was performed through Medline and PubMed up to september 1, 2019.The key words used were cannabis,marijuana,marihuana,hashish,hashich,cannabinoids,tetrahydrocannabinol,THC,dronabinol,nabilone,nabiximols,cannabidiol,
CBD, randomized,randomised,double-blind,simple blind,placebo-controlled and human. For the final selection,only properly controlled clinical trials were retained,thus open-label studies were excluded.
Mohamed Ben Amar is a pharmacist, specialized in clinical biology and pharmacology, graduated from the University Paul Sabatier ( Toulouse,France ) and the University of Montreal (Montreal,Canada). He is a professor of pharmacology and toxicology at the University of Montreal since 1980 and a researcher in psychotropic drugs, HIV-AIDS and cancer. He is author or co-author of 23 books, 105 publications, 61 scientific communications and 156 interviews with the media. He has acted as an expert witness in psychotropic drugs in 2001 and 2008 in front of Senate Commitees of the Government of Canada. He is curretly a consultant in cannabis and cannabinoids for the heath ministry of the GovernemPt of Quebec.